mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knox, SJ; Peehl, DM; Tian, J | 1 |
| Sharifi, N; Thomas, R | 1 |
| Bhattacharyya, RS; Feldman, D; Husbeck, B; Knox, SJ | 1 |
3 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Prostatic Neoplasms
| Article | Year |
|---|---|
Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; Blotting, Western; Catalase; Cell Proliferation; Drug Synergism; Glutathione; Glutathione Reductase; Humans; Hydrogen Peroxide; Hydroxyl Radical; Liver Neoplasms; Male; Manganese; Membrane Potential, Mitochondrial; Metalloporphyrins; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Pancreatic Neoplasms; Prostatic Neoplasms; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured | 2010 |
SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Cell Cycle; Cell Line, Tumor; Cyclic N-Oxides; Humans; Male; Metalloporphyrins; Mice; Mice, Inbred NOD; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Spin Labels; Superoxide Dismutase; Xenograft Model Antitumor Assays | 2012 |
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Topics: Acetylcysteine; Androgen Receptor Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Glutathione; Humans; Male; Metalloporphyrins; Metribolone; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Signal Transduction; Sodium Selenite; Sp1 Transcription Factor; Superoxides; Tumor Cells, Cultured | 2006 |